These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7957419)

  • 1. Temporary inhibition of growth and adrenal suppression associated with the use of steroid nose drops.
    Daman Willems CE; Dinwiddie R; Grant DB; Rivers RP; Zahir M
    Eur J Pediatr; 1994 Sep; 153(9):632-4. PubMed ID: 7957419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary results of a pilot study investigating the potential of salivary cortisol measurements to detect occult adrenal suppression secondary to steroid nose drops.
    Patel RS; Wallace AM; Hinnie J; McGarry GW
    Clin Otolaryngol Allied Sci; 2001 Jun; 26(3):231-4. PubMed ID: 11437848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenal suppression with intranasal betamethasone drops.
    Flynn MD; Beasley P; Tooke JE
    J Laryngol Otol; 1992 Sep; 106(9):827-8. PubMed ID: 1431525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intranasal betamethasone-17-valerate on perennial rhinitis and adrenal function.
    Czarny D; Brostoff J
    Lancet; 1968 Jul; 2(7561):188-90. PubMed ID: 4173404
    [No Abstract]   [Full Text] [Related]  

  • 5. Childhood Cushing's syndrome induced by betamethasone nose drops, and repeat prescriptions.
    Findlay CA; Macdonald JF; Wallace AM; Geddes N; Donaldson MD
    BMJ; 1998 Sep; 317(7160):739-40. PubMed ID: 9732346
    [No Abstract]   [Full Text] [Related]  

  • 6. Adrenal function during topical oral corticosteroid treatment.
    Lehner T; Lyne C
    Br Med J; 1969 Oct; 4(5676):138-41. PubMed ID: 4309863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal betamethasone induced acne and adrenal suppression.
    Bong JL; Connell JM; Lever R
    Br J Dermatol; 2000 Mar; 142(3):579-80. PubMed ID: 10777272
    [No Abstract]   [Full Text] [Related]  

  • 8. Superpotent topical steroid treatment of psoriasis vulgaris--clinical efficacy and adrenal function.
    Katz HI; Hien NT; Prawer SE; Mastbaum LI; Mooney JJ; Samson CR
    J Am Acad Dermatol; 1987 Apr; 16(4):804-11. PubMed ID: 3553247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: Effect of B17-V inhalation on hypothalamic-pituitary-adrenal axis and on growth in asthmatic children.
    Friedman M; Frears J
    Arch Dis Child; 1974 Sep; 49(9):747-8. PubMed ID: 4419367
    [No Abstract]   [Full Text] [Related]  

  • 10. Super potent topical corticosteroid use associated with adrenal suppression: clinical considerations.
    Gilbertson EO; Spellman MC; Piacquadio DJ; Mulford MI
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 2):318-21. PubMed ID: 9486706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cushing's syndrome induced by betamethasone nose drops. Children taking intranasal corticosteroids should be monitored for growth retardation.
    Malozowski S; Purucker M; Worobec A
    BMJ; 1999 May; 318(7194):1355. PubMed ID: 10383213
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cushing's syndrome and adrenal suppression by means of intranasal use of dexamethasone preparations].
    Reiner M; Galeazzi RL; Studer H
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1836-7. PubMed ID: 929148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of hypothalamo-pituitary-adrenal function in the rat after prolonged treatment with betamethasone.
    Hodges JR; Mitchley S
    Br J Pharmacol; 1970 Dec; 40(4):732-9. PubMed ID: 4322042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenal suppression after corticosteroid injection of periocular hemangiomas.
    Weiss AH
    Am J Ophthalmol; 1989 May; 107(5):518-22. PubMed ID: 2540659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of intranasal steroid spray (mometasone furoate) on treatment of patients with seasonal allergic rhinitis: comparison with oral corticosteroids.
    Karaki M; Akiyama K; Mori N
    Auris Nasus Larynx; 2013 Jun; 40(3):277-81. PubMed ID: 23127728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid aerosols in asthma: an assessment of betamethasone valerate and a 12-month study of patients on maintenance treatment.
    McAllen MK; Kochanowski SJ; Shaw KM
    Br Med J; 1974 Feb; 1(5900):171-5. PubMed ID: 4590668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of the best head position for instillation of steroid nose drops.
    Kayarkar R; Clifton NJ; Woolford TJ
    Clin Otolaryngol Allied Sci; 2002 Feb; 27(1):18-21. PubMed ID: 11903366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis.
    Beer H; Southern KW; Swift AC
    Cochrane Database Syst Rev; 2011 May; (5):CD008253. PubMed ID: 21563167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic-pituitary-adrenal function and growth in asthmatic children on long term betamethasone valerate aerosol.
    Friedman M; Frears J
    Postgrad Med J; 1974 Sep; 50 suppl 4():33-7. PubMed ID: 4467153
    [No Abstract]   [Full Text] [Related]  

  • 20. Cushing's syndrome induced by betamethasone nose drops. In rhinological disease betamethasone should be regarded as systemic corticosteroid.
    Homer JJ; Gazis TG
    BMJ; 1999 May; 318(7194):1355. PubMed ID: 10323840
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.